Recursion Pharmaceuticals (RXRX) Puts Fred Hassan In The Chair After Phase 2 Win

Recursion Pharmaceuticals (NasdaqGS:RXRX) reported positive Phase 2 data for oral MEK1/2 inhibitor REC-4881 in familial ...

Recursion Reports Third Quarter 2026 Financial Results and Extends Cash Runway; Highlights Positive Clinical Data in REC-4881 and REC-1245, Sanofi Development Candidate Option ...

IGC in an expanded adult population aged 18 years and older show deep, durable polyp burden reductions in FAP, with activity throughout the GI tract and in larger, higher-risk polyps.REC-4881 shows ...

Recursion targets REC-4881 registrational study in 2H 2027 while expecting cash runway into 2029

Recursion Q3 2026 earnings: clinical wins for REC-4881 and REC-1245, Sanofi progress, and cash runway to 2029.
GEN - Genetic Engineering and Biotechnology News

Recursion Eyes H2 2027 Pivotal Trial for Lead Candidate After Positive Phase II FAP Data

Recursion said it expects to launch its first registrational trial in the second half of this year for its lead candidate REC-4881 based on talks with the FDA, after the oral familial adenomatous ...
CNN

Recursion Pharmaceuticals, Inc. Class A

RXRX is trading in the middle of its 52-week range and near its 200-day simple moving average. Price change The price of RXRX shares has increased $0.02 since the market last closed. This is a 0.57% ...
The Windows Club

How to check Background apps using Internet in Windows 11

A day might come when you may need to find out which one of your Windows 11/10 applications is using the internet in the background. Instead of checking each app individually, you can do this more ...